Loading...
For the past decade, the potential of antihypertensive agents to affect the incidence of Parkinson disease (PD) has been evaluated by various methodologies, yielding a confusing array of conclusions. Now, researchers have conducted a careful case-control study of incident PD diagnosis and its association with various antihypertensives. They identified 3637 patients with incident PD and 3637 well-matched controls from the U.K.-based General Practice Research Database, which contained at least 3 years of data before the index (diagnosis) date for each participant. The authors separately analyzed four major classes of antihypertensive drugs: angiotensin-converting enzyme inhibitors, calcium channel blockers, angiotensin II antagonists, and bet…